ArticleBlood advances2020

Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma.

Masato Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.